Praxis Precision Medicines (PRAX) Misses Q4 EPS by 41c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 EPS of ($3.50), $0.41 worse than the analyst estimate of ($3.09).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Marvell (MRVL) Reiterated at Buy by Stifel on Position Across Connectivity Topologies
• Espey Manufacturing (ESP) Tops Q4 EPS by 24c
• Apertura Gene Therapy grants Lexeo access to BBB-crossing capsid